Biogen Inc. said the U.S. Food and Drug Administration has accepted its application seeking approval of BIIB800, a proposed biosimilar to Actemra. "Biogen: FDA Accepts Application for Actemra Biosimilar," at 7:50 a.m. ET, incorrectly said the European Medicines Agency had accepted the application.

(END) Dow Jones Newswires

December 09, 2022 09:26 ET (14:26 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Roche (QX) Charts.